274
Views
16
CrossRef citations to date
0
Altmetric
VEGF and Cervical Cancer

Vascular endothelial growth factor C enhances cervical cancer cell invasiveness via upregulation of galectin-3 protein

, , &
Pages 461-465 | Received 06 Nov 2013, Accepted 21 Feb 2014, Published online: 20 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yang Cheng, Shuyi Jiang, Jin Yuan, Junxiu Liu & Tommaso Simoncini. (2018) Vascular endothelial growth factor C promotes cervical cancer cell invasiveness via regulation of microRNA-326/cortactin expression. Gynecological Endocrinology 34:10, pages 853-858.
Read now

Articles from other publishers (15)

Meilin Yin & Yanhua Weng. (2023) Eight Aging-Related Genes Prognostic Signature for Cervical Cancer. International Journal of Genomics 2023, pages 1-41.
Crossref
Norhan B.B. Mohammed, Aristotelis Antonopoulos, Anne Dell, Stuart M. Haslam & Charles J. Dimitroff. 2023. Novel Methods and Pathways in Cancer Glycobiology Research. Novel Methods and Pathways in Cancer Glycobiology Research 157 193 .
Brooke V. Hisrich, R. Brant Young, Alison M. Sansone, Zachary Bowens, Lisa J. Green, Bruce A. Lessey & Anna V. Blenda. (2020) Role of Human Galectins in Inflammation and Cancers Associated with Endometriosis. Biomolecules 10:2, pages 230.
Crossref
Lili Han, Sulaiya Husaiyin, Chunhua Ma & Mayinuer Niyazi. (2019) Association study between the polymorphisms of angiogenesis‐related genes and cervical cancer susceptibility in Chinese Uygur population. Molecular Genetics & Genomic Medicine 7:10.
Crossref
Min Yang, Min Wang, Xianping Li, Yixin Xie, Xiaomeng Xia, Jingjing Tian, Kan Zhang & Aiguo Tang. (2018) The role of lncRNAs in signaling pathway implicated in CC. Journal of Cellular Biochemistry 120:3, pages 2703-2712.
Crossref
Bernd Peter Kost, Susanne Beyer, Lennard Schröder, Junyan Zhou, Doris Mayr, Christina Kuhn, Sandra Schulze, Simone Hofmann, Sven Mahner, Udo Jeschke & Helene Heidegger. (2018) Glucocorticoid receptor in cervical cancer: an immunhistochemical analysis. Archives of Gynecology and Obstetrics 299:1, pages 203-209.
Crossref
Lufang Wang, Yanyan Zhao, Yanshi Wang & Xin Wu. (2018) The Role of Galectins in Cervical Cancer Biology and Progression. BioMed Research International 2018, pages 1-11.
Crossref
Pingping Tao, Hao Wen, Binlie Yang, Ai Zhang, Xiaohua Wu & Qing Li. (2017) miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC. Experimental and Therapeutic Medicine.
Crossref
Jing Wang & Xiujuan Yue. (2017) Role and importance of the expression of transcription factor FOXC2 in cervical cancer. Oncology Letters.
Crossref
Susanne Beyer, Junyan Zhu, Doris Mayr, Christina Kuhn, Sandra Schulze, Simone Hofmann, Christian Dannecker, Udo Jeschke & Bernd Kost. (2017) Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer. International Journal of Molecular Sciences 18:3, pages 477.
Crossref
M. Li, Y.M. Feng & S.Q. Fang. (2017) Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer. Brazilian Journal of Medical and Biological Research 50:4.
Crossref
S.W. Aziz & M.H. Aziz. 2017. Introduction to Cancer Metastasis. Introduction to Cancer Metastasis 77 94 .
Masoud Zeinali, Armin Adelinik, Shaghayegh Papian, Hossein Khorramdelazad & Mehdi Abedinzadeh. (2015) Role of galectin-3 in the pathogenesis of bladder transitional cell carcinoma. Human Immunology 76:10, pages 770-774.
Crossref
HAIPENG ZHU, FENG YUN, XIAOXUE SHI & DONG WANG. (2015) VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin. Molecular Medicine Reports 12:2, pages 3163-3169.
Crossref
Nandor Gabor Than, Roberto Romero, Andrea Balogh, Eva Karpati, Salvatore Andrea Mastrolia, Orna Staretz-Chacham, Sinuhe Hahn, Offer Erez, Zoltan Papp & Chong Jai Kim. (2015) Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia. Journal of Pathology and Translational Medicine 49:3, pages 181-208.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.